Julian Praceus presents the concept of an AI & Cloud-based platform for structural heart interventions in the ICI Start-up Competition in Tel-Aviv.
LARALAB Platform is used in R&D and early trial stages of three Mitral & Tricuspid devices.
Founders Julian Praceus, Alex Vasilev and Julian Bernard kick-off LARALAB's business with the first one-room office in Munich.
LARALAB appoints Dr. Peter Vorländer, former Philips Innovation Lead and Managing Director Philips Medical Systems GmbH to LARALAB's Board.
LARALAB wins Munich Marathon Team Competition.
The LARALAB Platform receives CE marking under MDR along with its tricuspid valve workflow.
The CE-marked LARALAB Platform is officially launched at the PCR congress in Paris.
LARALAB's first generation of Deep Learning segmentations from Cardiac CT indicates potential performance beyond-state-of-the-art.
LARALAB was selected for the Philips Global AI start-up program from 700 start-ups: the only one in a pre-funding stage.
Julian Praceus presents a new decision-support concept for Mitral & Tricuspid interventions at CSI Frankfurt.
LARALAB successfully completes proof-of-concept for automatic algorithms in collaboration with Prof. Dr. Jeffrey J. Popma and Dr. Felix Kreidel.
LARALAB closes Series A financing round with the goal to bring the LARALAB Platform to the market.
LARALAB grows to a competitive team of 10.
LARALAB gets Quality Management System certified by TÜV Süd, in accordance with ISO 13485 and Medical Device Regulation (MDR) 2017/745.
LARALAB grows to 20 team members and plays the first LARALAB open.
LARALAB celebrates the opening of the new headquarters in Munich.
LARALAB launches advanced mitral valve workflow for investigational and research use by selected partners.
LARALAB raises 5.7M € in a Series A2 round to further drive platform innovations together with partnering heart centers and device companies.